Neuroblastoma Diagnosis, Therapy, and Prognosis /

Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnet...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Hayat, M.A (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Dordrecht : Springer Netherlands, 2012.
Σειρά:Pediatric Cancer, 1
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02391nam a22004935i 4500
001 978-94-007-2418-1
003 DE-He213
005 20151126001136.0
007 cr nn 008mamaa
008 111101s2012 ne | s |||| 0|eng d
020 |a 9789400724181  |9 978-94-007-2418-1 
024 7 |a 10.1007/978-94-007-2418-1  |2 doi 
040 |d GrThAP 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Neuroblastoma  |h [electronic resource] :  |b Diagnosis, Therapy, and Prognosis /  |c edited by M.A. Hayat. 
264 1 |a Dordrecht :  |b Springer Netherlands,  |c 2012. 
300 |a XVIII, 262 p. 40 illus., 24 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Pediatric Cancer,  |x 2211-7997 ;  |v 1 
520 |a Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnetic resonance imaging and  spectroscopy are detailed for diagnosing this solid, extracranial cancer. Targets for therapeutic intervention in neuroblastoma are identified, including targeting multidrug resistance in this cancer. Ornithine decarboxylase and polyamines are novel targets for therapeutic intervention. The effectiveness of chemotherapy with oral irinotecan and temozolomide is explained. The role of transcription factors (GATA) in neuroblastoma pregression is  also included. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Radiology. 
650 0 |a Pediatrics. 
650 0 |a Pediatric surgery. 
650 1 4 |a Biomedicine. 
650 2 4 |a Cancer Research. 
650 2 4 |a Pediatrics. 
650 2 4 |a Diagnostic Radiology. 
650 2 4 |a Pediatric Surgery. 
700 1 |a Hayat, M.A.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9789400724174 
830 0 |a Pediatric Cancer,  |x 2211-7997 ;  |v 1 
856 4 0 |u http://dx.doi.org/10.1007/978-94-007-2418-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)